ATE534401T1 - Mage antigen gekoppelt an einem protein d fragment enthaltende impfstoffe - Google Patents
Mage antigen gekoppelt an einem protein d fragment enthaltende impfstoffeInfo
- Publication number
- ATE534401T1 ATE534401T1 AT07121675T AT07121675T ATE534401T1 AT E534401 T1 ATE534401 T1 AT E534401T1 AT 07121675 T AT07121675 T AT 07121675T AT 07121675 T AT07121675 T AT 07121675T AT E534401 T1 ATE534401 T1 AT E534401T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- fragment
- vaccines containing
- antigen coupled
- mage antigen
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 238000012737 microarray-based gene expression Methods 0.000 title abstract 2
- 238000012243 multiplex automated genomic engineering Methods 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 229940035032 monophosphoryl lipid a Drugs 0.000 abstract 2
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 101710188053 Protein D Proteins 0.000 abstract 1
- 101710132893 Resolvase Proteins 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 abstract 1
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
- 229930182490 saponin Natural products 0.000 abstract 1
- 150000007949 saponins Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Permanent Magnet Type Synchronous Machine (AREA)
- Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0025574A GB0025574D0 (en) | 2000-10-18 | 2000-10-18 | Vaccine |
| GB0025573A GB0025573D0 (en) | 2000-10-18 | 2000-10-18 | Vaccine |
| US09/690,921 US6544518B1 (en) | 1999-04-19 | 2000-10-18 | Vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE534401T1 true ATE534401T1 (de) | 2011-12-15 |
Family
ID=34082077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07121675T ATE534401T1 (de) | 2000-10-18 | 2001-10-16 | Mage antigen gekoppelt an einem protein d fragment enthaltende impfstoffe |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050019340A1 (de) |
| EP (1) | EP2266603B1 (de) |
| JP (1) | JP2008285487A (de) |
| KR (1) | KR100831139B1 (de) |
| AT (1) | ATE534401T1 (de) |
| CY (3) | CY1108526T1 (de) |
| DE (1) | DE60131670T2 (de) |
| DK (2) | DK2266603T3 (de) |
| ES (2) | ES2392943T3 (de) |
| IL (1) | IL155282A (de) |
| PL (1) | PL211151B1 (de) |
| PT (3) | PT2266603E (de) |
| SI (1) | SI2266603T1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| ES2628744T3 (es) | 1998-05-22 | 2017-08-03 | Ottawa Hospital Research Institute | Métodos y productos para inducir inmunidad en mucosas |
| US20040053880A1 (en) * | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7569553B2 (en) * | 2002-07-03 | 2009-08-04 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7576066B2 (en) * | 2002-07-03 | 2009-08-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7605138B2 (en) * | 2002-07-03 | 2009-10-20 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| US7807803B2 (en) * | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
| AU2003300919A1 (en) * | 2002-12-11 | 2004-06-30 | Coley Pharmaceutical Gmbh | 5' cpg nucleic acids and methods of use |
| WO2004087203A2 (en) * | 2003-04-02 | 2004-10-14 | Coley Pharmaceutical Group, Ltd. | Immunostimulatory nucleic acid oil-in-water formulations for topical application |
| ES2395818T3 (es) * | 2004-07-13 | 2013-02-15 | Charite - Universitatsmedizin Berlin | Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3238190A (en) | 1963-10-23 | 1966-03-01 | Madaus & Co K G Fa Dr | Aescin recovery |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4806350A (en) * | 1986-04-18 | 1989-02-21 | Norden Laboratories, Inc. | Vaccine formulation |
| US6222020B1 (en) | 1987-01-07 | 2001-04-24 | Imperial Cancer Research Technology Limited | Antigens derived from the core protein of the human mammary epithelial mucin |
| WO1988005054A1 (en) | 1987-01-07 | 1988-07-14 | Imperial Cancer Research Technology Limited | Probe |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US4963484A (en) | 1988-01-29 | 1990-10-16 | Dana-Farber Cancer Institute, Inc. | Genetically engineered polypeptides with determinants of the human DF3 breast carcinoma-associated antigen |
| US5278302A (en) | 1988-05-26 | 1994-01-11 | University Patents, Inc. | Polynucleotide phosphorodithioates |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| ATE115862T1 (de) | 1989-02-04 | 1995-01-15 | Akzo Nobel Nv | Tocole als impfstoffadjuvans. |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| FR2649013B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
| FR2649012B1 (fr) | 1989-07-03 | 1991-10-25 | Seppic Sa | Emulsions multiphasiques injectables |
| US5256643A (en) | 1990-05-29 | 1993-10-26 | The Government Of The United States | Human cripto protein |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| CA2085827C (en) | 1991-12-23 | 2003-10-14 | Lucas A. T. Hilgers | Adjuvant composition containing synthetic hydrophobic lipopolysaccharide |
| DE69327599T2 (de) | 1992-06-25 | 2000-08-10 | Smithkline Beecham Biolog | Adjuvantien enthaltende Impfstoffzusammensetzung |
| US5786148A (en) | 1996-11-05 | 1998-07-28 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a novel prostate-specific kallikrein |
| US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| AU685443B2 (en) * | 1993-03-23 | 1998-01-22 | Smithkline Beecham Biologicals (Sa) | Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| US5744144A (en) | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| RU2154068C2 (ru) | 1993-11-17 | 2000-08-10 | Лаборатуар Ом С.А. | Глюкозаминовые дисахариды, способ их получения, фармацевтическая композиция |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US5688506A (en) | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
| WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
| ATE420171T1 (de) | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| GB9620795D0 (en) | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
| US5668267A (en) | 1995-05-31 | 1997-09-16 | Washington University | Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
| US5981215A (en) | 1995-06-06 | 1999-11-09 | Human Genome Sciences, Inc. | Human criptin growth factor |
| US5666153A (en) | 1995-10-03 | 1997-09-09 | Virtual Shopping, Inc. | Retractable teleconferencing apparatus |
| US7184826B2 (en) | 1996-06-18 | 2007-02-27 | Alza Corporation | Device and method for enhancing transdermal flux of agents being delivered or sampled |
| CN1150001C (zh) | 1996-07-03 | 2004-05-19 | 卫材株式会社 | 含有脂质a类似物的注射剂及其制备方法 |
| US5955306A (en) | 1996-09-17 | 1999-09-21 | Millenium Pharmaceuticals, Inc. | Genes encoding proteins that interact with the tub protein |
| EP0930893B1 (de) | 1996-10-11 | 2005-04-13 | The Regents of The University of California | Immunostimulierende oligonucleotidekonjugate |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| US6231859B1 (en) * | 1996-12-02 | 2001-05-15 | Aquila Biopharmaceuticals, Inc. | Saponin adjuvant compositions |
| ES2195190T3 (es) | 1996-12-20 | 2003-12-01 | Alza Corp | Dispositivo y metodo para mejorar el flujo de agente transdermico. |
| US5840871A (en) | 1997-01-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Prostate-associated kallikrein |
| ES2248891T3 (es) | 1997-02-25 | 2006-03-16 | Corixa Corporation | Compuestos para inmunodiagnostico de cancer de prostata y metodos para su uso. |
| JP3036686B2 (ja) | 1997-02-27 | 2000-04-24 | 政夫 高橋 | 冠状動脈のバイパス手術に用いる血管吻合部の止血保持装置 |
| US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| PL190237B1 (pl) | 1997-04-01 | 2005-11-30 | Corixa Corp | Kompozycja adiuwantowa, szczepionka, sposób wytwarzania kompozycji adiuwantowej oraz zastosowanie |
| ZA982968B (en) | 1997-04-09 | 1998-10-27 | Corixa Corp | Compositions and methods for the treatment and diagnosis of breast cancer |
| US6130043A (en) | 1997-05-02 | 2000-10-10 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the prostate |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| EP0988053A1 (de) | 1997-06-11 | 2000-03-29 | Aquila Biopharmaceuticals, Inc. | Gereinigte saponinen als orale adjuvantien |
| CA2654522C (en) | 1997-08-29 | 2014-01-28 | Antigenics Inc. | Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as exipient |
| EP1279401B1 (de) | 1997-09-05 | 2008-01-09 | GlaxoSmithKline Biologicals S.A. | Öl-in-Wasser Emulsionen mit Saponinen |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| WO1999019479A1 (en) | 1997-09-26 | 1999-04-22 | Corixa Corporation | Murine model for human carcinoma |
| HUP0101139A3 (en) | 1997-12-02 | 2003-11-28 | Powderject Vaccines Inc Madiso | Transdermal delivery of particulate vaccine compositions |
| AU2010699A (en) | 1997-12-24 | 1999-07-19 | Corixa Corporation | Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse |
| CA2319309C (en) | 1998-02-05 | 2010-08-10 | Smithkline Beecham Biologicals S.A. | Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| AU3560399A (en) | 1998-04-15 | 1999-11-01 | Ludwig Institute For Cancer Research | Tumor associated nucleic acids and uses therefor |
| ES2628744T3 (es) * | 1998-05-22 | 2017-08-03 | Ottawa Hospital Research Institute | Métodos y productos para inducir inmunidad en mucosas |
| TW200532020A (en) | 1998-07-14 | 2005-10-01 | Corixa Corp | Compositions and methods for therapy and diagnosis of prostate cancer |
| WO2000009159A1 (en) * | 1998-08-10 | 2000-02-24 | Aquila Biopharmaceuticals, Inc. | Compositions of cpg and saponin adjuvants and methods thereof |
| AU760203B2 (en) | 1999-01-18 | 2003-05-08 | Earth Chemical Co. Ltd. | Aerosol diffusion fogger |
| CN1201004C (zh) | 1999-01-29 | 2005-05-11 | 考丽克萨有限公司 | HER－2/neu融合蛋白 |
| AU3391200A (en) | 1999-03-04 | 2000-09-21 | Corixa Corporation | Compositions and methods for breast cancer therapy and diagnosis |
| GB9905124D0 (en) * | 1999-03-05 | 1999-04-28 | Smithkline Beecham Biolog | Novel compounds |
| US6558670B1 (en) * | 1999-04-19 | 2003-05-06 | Smithkline Beechman Biologicals S.A. | Vaccine adjuvants |
| HK1044484B (en) * | 1999-04-19 | 2005-07-29 | Smithkline Beecham Biologicals S.A. | Adjuvant composition containing saponin and immunostimulatory oligonucleotide |
| AU5788900A (en) * | 1999-07-07 | 2001-01-22 | Tularik Inc. | Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides |
| SI1265915T1 (sl) * | 2000-02-23 | 2011-02-28 | Glaxosmithkline Biolog Sa | Nove spojine |
| WO2010136443A1 (en) * | 2009-05-27 | 2010-12-02 | Glaxosmithkline Biologicals S.A. | Casb7439 constructs |
-
2001
- 2001-10-16 US US10/478,188 patent/US20050019340A1/en not_active Abandoned
- 2001-10-16 KR KR1020037005465A patent/KR100831139B1/ko not_active Expired - Fee Related
- 2001-10-16 DK DK10170408.8T patent/DK2266603T3/da active
- 2001-10-16 AT AT07121675T patent/ATE534401T1/de active
- 2001-10-16 PT PT10170408T patent/PT2266603E/pt unknown
- 2001-10-16 ES ES10170408T patent/ES2392943T3/es not_active Expired - Lifetime
- 2001-10-16 PT PT07121675T patent/PT1889630E/pt unknown
- 2001-10-16 PL PL391896A patent/PL211151B1/pl unknown
- 2001-10-16 EP EP10170408A patent/EP2266603B1/de not_active Expired - Lifetime
- 2001-10-16 PT PT01987671T patent/PT1326638E/pt unknown
- 2001-10-16 DK DK07121675.8T patent/DK1889630T3/da active
- 2001-10-16 DE DE60131670T patent/DE60131670T2/de not_active Expired - Lifetime
- 2001-10-16 ES ES07121675T patent/ES2377077T3/es not_active Expired - Lifetime
- 2001-10-16 SI SI200131015T patent/SI2266603T1/sl unknown
-
2003
- 2003-04-08 IL IL155282A patent/IL155282A/en not_active IP Right Cessation
-
2008
- 2008-01-31 CY CY20081100112T patent/CY1108526T1/el unknown
- 2008-05-14 JP JP2008126888A patent/JP2008285487A/ja active Pending
-
2012
- 2012-02-14 CY CY20121100147T patent/CY1112658T1/el unknown
- 2012-10-26 CY CY20121101024T patent/CY1113735T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1112658T1 (el) | 2016-02-10 |
| DE60131670D1 (de) | 2008-01-10 |
| CY1113735T1 (el) | 2016-06-22 |
| ES2392943T3 (es) | 2012-12-17 |
| KR100831139B1 (ko) | 2008-05-20 |
| HK1147673A1 (en) | 2011-08-19 |
| JP2008285487A (ja) | 2008-11-27 |
| DE60131670T2 (de) | 2008-10-30 |
| PT2266603E (pt) | 2012-11-02 |
| PL211151B1 (pl) | 2012-04-30 |
| SI2266603T1 (sl) | 2012-12-31 |
| CY1108526T1 (el) | 2014-04-09 |
| PT1889630E (pt) | 2012-02-29 |
| PT1326638E (pt) | 2008-02-06 |
| EP2266603B1 (de) | 2012-09-12 |
| EP2266603A1 (de) | 2010-12-29 |
| HK1057992A1 (en) | 2004-04-30 |
| KR20030044015A (ko) | 2003-06-02 |
| IL155282A (en) | 2010-11-30 |
| DK2266603T3 (da) | 2012-11-05 |
| DK1889630T3 (da) | 2012-03-05 |
| ES2377077T3 (es) | 2012-03-22 |
| HK1117729A1 (en) | 2009-01-23 |
| US20050019340A1 (en) | 2005-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113735T1 (el) | Εμβολια ογκου | |
| PT1104306E (pt) | Composicoes de cpg e adjuvantes de saponina e seus metodos | |
| DK1147117T3 (da) | Immunologiske adjuvansforbindelser | |
| BR0114786A (pt) | Composição imunogênica, método de tratamento de um paciente que sofre de, ou que é suscetìvel a, um câncer, e, uso de uma combinação de uma saponina, um oligotìdeo imunoestimulador e um antìgeno de câncer, e, método para a manufatura de uma composição | |
| WO2003011223A3 (en) | Immunomodulatory compounds and methods of use thereof | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| ATE475668T1 (de) | Immunisierung durch impfung von dns transkriptionseinheit | |
| ATE406912T1 (de) | Immunisierung gegen chlamydia tracheomatis | |
| DE60012711D1 (de) | Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe | |
| EP0705109A4 (de) | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus | |
| CA2185470A1 (en) | Compositions and methods for vaccines comprising .alpha.-galactosyl epitopes | |
| EP1220925B8 (de) | Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen | |
| RU2006138283A (ru) | Поливалентная вакцина для иммунотерапии рака на основе mage-3 и ny-eso-1 | |
| ATE370745T1 (de) | Verbesserte polysaccharid- und glykokonjugat- vakzine | |
| DK1140152T3 (da) | Fremgangsmåde til fremstilling af inaktiverede v/o-emulsion-adjuvans-vacciner | |
| WO2000050073A3 (en) | Caulobacter lps immunoadjuvant | |
| WO2002009752A3 (en) | Immunological adjuvant compounds | |
| DK0626008T3 (da) | Vaccine, der som en adjuvans indeholder acemannan | |
| EA200800917A1 (ru) | Адъюванты для вакцин | |
| ATE345812T1 (de) | Antigen-mimotope und vakzine gegen krebserkrankungen | |
| DK1913957T3 (da) | Genetiske adjuvant-vacciner |